Champions Oncology (CSBR) EBT (2010 - 2026)
Champions Oncology (CSBR) posted quarterly EBT of -$495000.0 for Q2 2026, up 74.8% year-over-year from -$283186.7 in Q2 2025, and down 108.86% quarter-over-quarter from -$237000.0 in Q1 2026.
Champions Oncology (CSBR) EBT (2010 - 2026) Analysis & Trends
Champions Oncology's EBT history runs 17 years deep, the most recent figure standing at -$495000.0 for Q2 2026.
- In Q2 2026, EBT rose 74.8% year-over-year to -$495000.0; the TTM figure through Apr 2026 stood at -$929000.0 (down 120.08% YoY), while the FY2026 annual figure was -$929000.0, down 120.08% from the prior year.
- EBT for Q2 2026 stood at -$495000.0, down from -$237000.0 in the prior quarter.
- The five-year high for EBT was $4.5 million in Q1 2025, with the low at -$2.5 million in Q2 2023.
- The 5-year median for EBT is -$324000.0 (2022), against an average of -$468000.0.
- The sharpest annual moves came in 2023 and 2025: EBT slumped 102900.0% in 2023, then jumped 279.36% in 2025.
- Champions Oncology's EBT stood at -$2000.0 in 2022, then plunged by 102900.0% to -$2.1 million in 2023, then surged by 135.87% to $739000.0 in 2024, then plunged by 65.49% to $255000.0 in 2025, then plunged by 294.12% to -$495000.0 in 2026.
- Business Quant data shows CSBR's EBT at -$495000.0 in Q2 2026, -$237000.0 in Q1 2026, and $255000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | -495,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -495,000.00 |
| Jan 31, 2026 | -237,000.00 |
| Oct 31, 2025 | 255,000.00 |
| Jul 31, 2025 | -452,000.00 |
| Apr 30, 2025 | -1.96 Mn |
| Jan 31, 2025 | 4.52 Mn |
| Oct 31, 2024 | 739,000.00 |
| Jul 31, 2024 | 1.33 Mn |
| Apr 30, 2024 | -190,000.00 |
| Jan 31, 2024 | -2.52 Mn |
| Oct 31, 2023 | -2.06 Mn |
| Jul 31, 2023 | -2.54 Mn |
| Apr 30, 2023 | -2.54 Mn |
| Jan 31, 2023 | -2.42 Mn |
| Oct 31, 2022 | -2,000.00 |
| Jul 31, 2022 | -302,000.00 |
| Apr 30, 2022 | -346,000.00 |
| Jan 31, 2022 | 798,000.00 |
| Oct 31, 2021 | 289,000.00 |
| Jul 31, 2021 | -158,000.00 |